<DOC>
	<DOC>NCT01529944</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to obtain the PTPN11 mutation status and investigate the impact of the PTPN11 mutation status on the effect of somatropin (Norditropin®) by use of data obtained in the GHNOO-1658 trial.</brief_summary>
	<brief_title>Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658</brief_title>
	<detailed_description />
	<mesh_term>Noonan Syndrome</mesh_term>
	<criteria>Participation in the GHNOO1658 trial Subject has completed genetic testing of PTPN11 mutation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>